| Recruiting | Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracos PONV | N/A | 2026-04-07 |
| Not Yet Recruiting | Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma Thymic Carcinoma | Phase 2 | 2026-04-01 |
| Recruiting | Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC | — | 2026-03-02 |
| Not Yet Recruiting | Renal Denervation Combined With Pulsed Field Ablation to Prevent Blanking-Period Recurrence in Persistent Atri Persistent Atrial Fibrillation | N/A | 2026-01-01 |
| Not Yet Recruiting | Epicardial Adipose Tissue-Targeted DApagliflozin for Reducing Electrical Remodeling in Atrial Fibrillation Atrial Fibrillation (AF) | N/A | 2026-01-01 |
| Not Yet Recruiting | The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension Advanced Lung Cancer | Phase 2 | 2026-01-01 |
| Not Yet Recruiting | SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes Lung Cancer | N/A | 2025-12-07 |
| Not Yet Recruiting | A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small C NSCLC | Phase 2 | 2025-12-01 |
| Recruiting | A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) | Phase 2 | 2025-09-23 |
| Recruiting | Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors Pulmonary Neuroendocrine Tumor | Phase 2 | 2025-09-22 |
| Not Yet Recruiting | Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules Lung Cancer (Diagnosis) | N/A | 2025-09-01 |
| Not Yet Recruiting | Clinical Validation Study on the Imaging Efficacy of Mobile 4D CBCT Technology for Peripheral Pulmonary Lesion Peripheral Pulmonary Lesions (PPLs) | — | 2025-09-01 |
| Recruiting | Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC Lung Cancer, Neoadjuvant Therapy | — | 2025-09-01 |
| Recruiting | Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation Persistent Atrial Fibrillation | N/A | 2025-07-16 |
| Recruiting | A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes Lung Lesions, Mediastinal and Hilar Lymph Node Enlargement | N/A | 2025-07-10 |
| Recruiting | RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs Peripheral Pulmonary Nodules | N/A | 2025-07-02 |
| Not Yet Recruiting | The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC Esophageal Cancer Stage III | Phase 2 | 2025-07-01 |
| Active Not Recruiting | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients W Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy, Induction Therapy | Phase 2 | 2025-07-01 |
| Not Yet Recruiting | Optical Biopsy and Cytological Evaluation for Intrathoracic Lymphadenopathy Intrathoracic Lymphadenopathy | N/A | 2025-07-01 |
| Completed | Shanghai Clinical Cohort - Esophageal Cancer Esophageal Cancer, Esophagectomy | — | 2025-07-01 |
| Not Yet Recruiting | A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib EGFR Mutation Positive Advanced Non Small Cell Lung Cancer, PD-L1 Positive | Phase 2 | 2025-06-30 |
| Active Not Recruiting | Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Ce OligoProgressive Metastatic Disease, Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2025-06-03 |
| Recruiting | Transbronchial MWA for Pulmonary Tumors Lung Cancer | N/A | 2025-05-12 |
| Not Yet Recruiting | MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer Lung Cancer (NSCLC) | N/A | 2025-05-01 |
| Not Yet Recruiting | A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combina KRAS G12C Lung Cancer | Phase 2 | 2025-04-30 |
| Not Yet Recruiting | Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCL ALK-Positive NSCLC | — | 2025-04-20 |
| Recruiting | Cryoablation vs Thoracoscopic Surgery for GGN Ground-Glass Opacity | N/A | 2025-04-20 |
| Recruiting | EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE Lymphadenopathy | N/A | 2025-04-01 |
| Not Yet Recruiting | GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy Lung Ground-Glass Opacity | N/A | 2025-04-01 |
| Not Yet Recruiting | Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC Lung Cancer | Phase 2 | 2025-03-31 |
| Active Not Recruiting | Intracardiac Echocardiography-Guided Catheter Ablation for Premature Ventricular Contractions Originating From Premature Ventricular Contractions | N/A | 2025-03-23 |
| Not Yet Recruiting | Efficacy of Mavacamten Combined With Radiofrequency Ablation in Patients With Symptomatic Obstructive Hypertro Obstructive Hypertrophic Cardiomyopathy, Mavacamten, Radiofrequency Ablation | N/A | 2025-02-26 |
| Not Yet Recruiting | Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Fie Atrial Fibrillation (AF) | N/A | 2025-02-24 |
| Recruiting | The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung C NSCLC | Phase 2 | 2025-02-20 |
| Recruiting | Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis Lung Cancer, Myocarditis Due to Drug | — | 2025-01-30 |
| Not Yet Recruiting | Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequ Atrial Fibrillation (AF) | N/A | 2025-01-01 |
| Not Yet Recruiting | Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation Atrial Fibrillation (AF) | N/A | 2024-12-25 |
| Not Yet Recruiting | Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablatio HFpEF - Heart Failure with Preserved Ejection Fraction, Atrial Fibrillation (AF) | N/A | 2024-12-16 |
| Not Yet Recruiting | Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation Atrial Fibrillation (AF) | N/A | 2024-12-16 |
| Not Yet Recruiting | A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated Lung Cancer, Non-Small Cell | Phase 1 / Phase 2 | 2024-12-15 |
| Recruiting | Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC Lung Cancer (NSCLC), Leptomeningeal Metastasis | Phase 1 | 2024-12-09 |
| Not Yet Recruiting | Sd-RAB for the Diagnosis of PPLs Peripheral Pulmonary Lesions | N/A | 2024-12-01 |
| Recruiting | Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer Lung Cancer, Non-Small Cell | Phase 2 | 2024-11-20 |
| Recruiting | A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy fo Esophageal Squamous Cell Carcinoma (ESCC) | Phase 2 | 2024-11-01 |
| Enrolling By Invitation | Perioperative Treatment Outcomes of Early NSCLC NSCLC | — | 2024-11-01 |
| Recruiting | Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination The Lung Cancer, Small Cell | Phase 2 | 2024-10-13 |
| Not Yet Recruiting | Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF Persistent Atrial Fibrillation | N/A | 2024-10-01 |
| Not Yet Recruiting | Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC Non-Small-Cell Lung Cancer | Phase 4 | 2024-10-01 |
| Recruiting | Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Pati Stage II-III Non-small Cell Lung Cancer | Phase 3 | 2024-09-12 |
| Not Yet Recruiting | Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer Non-small Cell Lung Cancer | N/A | 2024-09-01 |
| Recruiting | Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI COPD, Lung Cancers | — | 2024-09-01 |
| Enrolling By Invitation | Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therap Non-Small-Cell Lung Cancer, Non-Small-Cell Lung Cancer Stage IV | — | 2024-08-16 |
| Completed | Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-in Lung Cancer | N/A | 2024-08-15 |
| Not Yet Recruiting | Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC KRAS Mutation-Related Tumors, Advanced Lung Cancer, Refractory Tumor | Phase 1 / Phase 2 | 2024-07-01 |
| Not Yet Recruiting | Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction Esophageal Cancer | Phase 2 | 2024-06-19 |
| Recruiting | Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) Esophageal Cancer | Phase 2 | 2024-06-17 |
| Not Yet Recruiting | A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Bal Atrial Fibrillation, Atrial Flutter | N/A | 2024-06-15 |
| Not Yet Recruiting | Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung Cancer Lung Cancer | N/A | 2024-06-05 |
| Not Yet Recruiting | Optical Biopsy for Peripheral Pulmonary Lesions Peripheral Pulmonary Lesions | — | 2024-06-01 |
| Recruiting | Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC Non-small Cell Lung Cancer | Phase 2 | 2024-04-02 |
| Unknown | Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endo Esophageal Neoplasm, Anastomotic Leak, Recurrent Laryngeal Nerve Injuries | — | 2024-04-01 |
| Recruiting | Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform Lung Cancer | N/A | 2024-03-24 |
| Enrolling By Invitation | The Novel Special Light for Endotracheal/Bronchial Lesions. Tracheal Disease, Bronchial Disease | — | 2024-01-31 |
| Unknown | Blinded Randomized Controlled Trial of Artificial Intelligence Guided Detection of Intracardiac Thrombus Atrial Fibrillation | N/A | 2024-01-05 |
| Recruiting | Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer Lung Cancer Stage IA | N/A | 2024-01-04 |
| Recruiting | A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema Severe Emphysema | N/A | 2024-01-01 |
| Not Yet Recruiting | RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy Surgical Procedure, Unspecified | N/A | 2024-01-01 |
| Recruiting | Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Carcinoma, Non-small Cell Lung Cancer | — | 2023-12-15 |
| Not Yet Recruiting | Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Tria Esophageal Squamous Cell Carcinoma | Phase 2 | 2023-12-01 |
| Recruiting | Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer Non Small Cell Lung Cancer | — | 2023-10-01 |
| Completed | A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Atrial Fibrillation, Cathter Ablation, Endpoint | N/A | 2023-08-01 |
| Active Not Recruiting | Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients Non-squamous NSCLC | Phase 2 | 2023-06-27 |
| Unknown | Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, C Lung Cancer | N/A | 2023-05-23 |
| Recruiting | A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC Non Small Cell Lung Cancer | — | 2023-05-08 |
| Active Not Recruiting | Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC | Phase 1 / Phase 2 | 2023-02-16 |
| Recruiting | Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer Esophageal Squamous Cell Carcinoma, Unresectable Locally Advanced Esophageal Cancer | Phase 1 / Phase 2 | 2023-01-10 |
| Completed | PerAF: AF Termination vs Prespecified Ablation Persistent Atrial Fibrillation | N/A | 2023-01-01 |
| Recruiting | Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | 2023-01-01 |
| Unknown | Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis Persistent Atrial Fibrillation | N/A | 2023-01-01 |
| Unknown | Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE- Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-12-25 |
| Active Not Recruiting | Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Canc Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy | Phase 2 | 2022-11-02 |
| Recruiting | First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutati Non-Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2022-10-13 |
| Unknown | Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation Atrial Fibrillation, Catheter Ablation | N/A | 2022-10-11 |
| Unknown | mCBCT in Combination With ENB for the Diagnosis of PPNs Peripheral Pulmonary Nodules, Lung Cancer | — | 2022-09-26 |
| Completed | Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs Peripheral Pulmonary Lesions | N/A | 2022-09-02 |
| Unknown | CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation Persistent Atrial Fibrillation | N/A | 2022-09-01 |
| Unknown | Comparison of Peri-procedural Complications of Intracardiac Echocardiography and Transesophageal Echocardiogra Atrial Fibrillation | N/A | 2022-08-01 |
| Unknown | Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Adva Non-Small Cell Lung Cancer | N/A | 2022-02-21 |
| Unknown | Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation Non-small Cell Lung Cancer, Minimal Residual Disease, Immunotherapy | Phase 2 | 2022-01-01 |
| Completed | Recurrent Persistent Atrial Fibrillation:In-situ Ablation Vs Extensive Ablation Recurrent Persistent Atrial Fibrillation | N/A | 2022-01-01 |
| Unknown | SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC NSCLC, Stage III | Phase 2 | 2022-01-01 |
| Recruiting | China Lung Cancer Screening (CLUS) Study Version 3.0 Lung Cancer | N/A | 2022-01-01 |
| Unknown | Augmented Reality-assisted Localization of Solitary Pulmonary Nodules for Precise Sublobar Lung Resection SPN, Lung Cancer | N/A | 2022-01-01 |
| Unknown | Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study Peripheral Pulmonary Lesion | — | 2021-12-23 |
| Unknown | Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation Persistent Atrial Fibrillation | N/A | 2021-12-01 |
| Unknown | Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Esophageal Squamous Cell Carcinomas | Phase 2 | 2021-12-01 |
| Unknown | Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis Persistent Atrial Fibrillation | N/A | 2021-12-01 |
| Unknown | Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis. Persistent Atrial Fibrillation | N/A | 2021-11-01 |
| Completed | Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement Persistent Atrial Fibrillation, Right Atrial Enlargement | — | 2021-11-01 |
| Active Not Recruiting | A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients NSCLC | Phase 2 | 2021-10-27 |
| Unknown | Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCL Non-Small-Cell Lung Cancer | Phase 2 | 2021-10-12 |
| Unknown | To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS. Extensive-Stage Small-Cell Lung Cancer | N/A | 2021-09-28 |
| Unknown | A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. NSCLC | Phase 2 | 2021-09-01 |
| Not Yet Recruiting | Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia Sinus Bradycardia | N/A | 2021-09-01 |
| Completed | Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and Type 2 Diabetes Mellitus (T2DM), Atrial Fibrillation (AF) | N/A | 2021-08-01 |
| Completed | Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients Non Small Cell Lung Cancer | Phase 1 | 2021-08-01 |
| Unknown | Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer Esophageal Cancer | — | 2021-08-01 |
| Unknown | Termination of Persistent Atrial Fibrillation by Catheter Ablation Atrial Fibrillation | — | 2021-08-01 |
| Unknown | Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Tr Lung Cancer, EGFR Gene Mutation | Phase 2 | 2021-07-15 |
| Unknown | To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cance NRG1-fused Non-small Cell Lung Cancer | Phase 4 | 2021-06-01 |
| Unknown | Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases NSCLC | Phase 3 | 2021-06-01 |
| Completed | Diagnostic Value of UTB and TB for PPL Peripheral Pulmonary Lesion | N/A | 2021-03-08 |
| Unknown | The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO Lung Ground-Glass Opacity | N/A | 2021-03-01 |
| Active Not Recruiting | Dacomitinib in Lung Cancer With Uncommon EGFR Mutations Non-small Cell Lung Cancer Metastatic, EGF-R Positive Non-Small Cell Lung Cancer | Phase 2 | 2020-12-08 |
| Unknown | Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase Lung Cancer | Phase 4 | 2020-12-01 |
| Completed | Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib Non-Small Cell Lung Cancer With EGFR Mutation, Locally Advanced Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | 2020-11-19 |
| Completed | Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC NSCLC Stage IV, Checkpoint Inhibitor | Phase 1 / Phase 2 | 2020-11-02 |
| Unknown | NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy Lung Cancer | — | 2020-11-01 |
| Unknown | Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients Adverse Reactions, Immune Checkpoint Inhibitor, Non-Small Cell Lung Cancer Patients | — | 2020-08-01 |
| Completed | The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation. Atrial Fibrillation, Persistent | N/A | 2020-08-01 |
| Unknown | ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC Lung Cancer | — | 2020-07-24 |
| Unknown | Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous Non Small Cell Lung Cancer | Phase 2 | 2020-07-15 |
| Unknown | Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions Non-small-cell Lung Cancer | Phase 2 | 2020-06-30 |
| Completed | AF Ablation for HF With Reduced EF Persistent Atrial Fibrillation, Heart Failure With Reduced Ejection Fraction | N/A | 2020-06-01 |
| Unknown | Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules Pulmonary Nodules | — | 2019-10-08 |
| Unknown | Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) Carcinoma, Non-small Cell Lung Cancer | Phase 2 | 2019-10-01 |
| Recruiting | Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carci Esophageal Cancer | Phase 3 | 2019-09-01 |
| Unknown | NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer Lung Neoplasms | — | 2019-08-30 |
| Completed | Pre-Surgery If Needed for Oesophageal Cancer Esophageal Cancer | — | 2019-08-08 |
| Unknown | cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation Lung Cancer | N/A | 2019-06-17 |
| Unknown | KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2019-05-22 |
| Unknown | Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer SCLC, Anlotinib | Phase 2 | 2019-05-01 |
| Unknown | Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer Esophageal Squamous Cell Carcinoma, Apatinib, Recurrence | Phase 2 | 2019-04-02 |
| Completed | ENB for the Diagnosis of PPNs:a Real World Study Peripheral Pulmonary Nodules | — | 2019-03-20 |
| Unknown | Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB Non Small Cell Lung Cancer | — | 2019-02-25 |
| Unknown | Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung Cancer Lung Cancer | N/A | 2019-01-01 |
| Recruiting | Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations NSCLC, NSCLC Stage IV, NSCLC, Recurrent | — | 2019-01-01 |
| Unknown | To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation Lung Squamous Cell Carcinoma | Phase 4 | 2018-11-27 |
| Unknown | China Lung Cancer Screening (CLUS) Study Version 2.0 Lung Neoplasms | N/A | 2018-08-01 |
| Unknown | First-line Combination Treatment Based on Anlotinib Lung Cancer, Advanced Stage | Phase 1 | 2018-07-20 |
| Unknown | ENB in the Diagnosis of Peripheral Pulmonary Nodules Peripheral Pulmonary Nodules | N/A | 2018-07-04 |
| Unknown | Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS Ultrasonography | — | 2018-07-01 |
| Unknown | Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes Lymph Node Disease | — | 2018-07-01 |
| Unknown | EBUS Image Features in the Diagnosis of PPLs Endobronchial Ultrasound | N/A | 2018-07-01 |
| Unknown | Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image Diagnoses Disease | — | 2018-07-01 |
| Unknown | A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant H Malignant Hydrothorax, NSCLC | — | 2018-05-18 |
| Unknown | ENB Guided MWA for Early-stage Peripheral Lung Cancer Lung Cancer | N/A | 2018-04-18 |
| Unknown | Transbronchial Ablation for Peripheral Lung Tumor Lung Cancer | N/A | 2018-02-07 |
| Unknown | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC Unresectable Stage III Non-small-cell Lung Cancer | Phase 3 | 2017-11-01 |
| Completed | Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy Lung Cancer | N/A | 2017-09-01 |
| Unknown | Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy Esophageal Cancer, Esophageal Carcinoma | Phase 3 | 2017-07-29 |
| Unknown | Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients Lung Nodule | — | 2017-06-01 |
| Unknown | Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma Pulmonary Large Cell Neuroendocrine Carcinoma | Phase 2 | 2016-12-01 |
| Unknown | Precision Diagnosis and Therapy for Early Stage Lung Cancer Lung Cancer | N/A | 2016-12-01 |
| Unknown | Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Contro Lung Adenocarcinoma | Phase 2 | 2016-12-01 |
| Unknown | To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer Non-small Cell Lung Cancer Stage IIIA, Radiotherapy | Phase 2 | 2016-11-01 |
| Unknown | SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations NSCLC, SBRT, GM-CSF | Phase 2 | 2016-11-01 |
| Unknown | 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter C Non-small-cell Lung Cancer | Phase 3 | 2016-11-01 |
| Unknown | Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer NSCLC | Phase 2 | 2016-11-01 |
| Terminated | To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Can Non-small Cell Lung Cancer Stage IIIA, Radiotherapy | Phase 3 | 2016-11-01 |
| Unknown | ENB Guided RFA for Early-stage Peripheral Lung Cancer Lung Cancer | N/A | 2016-09-01 |
| Recruiting | Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer Non-Small Cell Lung Cancer | — | 2016-07-21 |
| Unknown | Catheter Ablation of Longstanding Persistent Atrial Fibrillation Atrial Fibrillation | N/A | 2016-05-01 |
| Unknown | Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer Lung Cancer | N/A | 2016-02-01 |
| Unknown | Percutaneous Cryoablation Peripheral Lung Cancer Lung Cancer | N/A | 2016-02-01 |
| Completed | UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs Lung Cancer | N/A | 2016-02-01 |
| Unknown | Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer Esophageal Cancer, Chemoradiation, Surgery | Phase 2 | 2016-01-01 |
| Recruiting | Molecular Analysis and Treatment Options of SCLC Small-cell Lung Cancer, Small Cell Lung Cancer, Combined Type, Small Cell Lung Carcinoma | — | 2016-01-01 |
| Recruiting | Association of Psychological Distress in Patients With Lung Cancer Lung Neoplasms, Psychological Distress, Prognosis Factors | — | 2016-01-01 |
| Unknown | Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC Non Small Cell Lung Cancer | Phase 2 | 2016-01-01 |
| Unknown | Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer Esophageal Neoplasms | Phase 3 | 2016-01-01 |
| Recruiting | Molecular Analysis and Treatment Options of Thymic Malignancies Thymic Epithelial Tumor, Thymic Carcinoma, Thymic Cancer | — | 2016-01-01 |
| Unknown | Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC SCLC | Phase 3 | 2015-12-01 |
| Completed | EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression Lung Adenocarcinoma, EGFR Activating Mutation | Phase 2 | 2015-01-01 |
| Completed | The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After L Tricuspid Regurgitation, Right Heart Failure | Phase 4 | 2014-11-01 |
| Unknown | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth F Non-Small Cell Lung Cancer, Brain Metastases, EGFR Gene Mutation | Phase 2 / Phase 3 | 2014-11-01 |
| Completed | ENB-GS-TBLB for the Diagnosis of PPLs Lung Cancer | N/A | 2014-07-01 |
| Unknown | Early Stage Lung Cancer Screening With Low-dose Computed Tomographic Lung Cancer | N/A | 2014-01-01 |
| Unknown | EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLs Lung Cancer | N/A | 2013-07-01 |
| Unknown | Recombinant BNP on Heart and Renal Function in Acute Heart Failure Acute Heart Failure, Acute Renal Failure | Phase 2 | 2012-07-01 |
| Temporarily Not Available | Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy Non-small Cell Lung Cancer | — | — |